New search Show text from Guidelines
D DERMATOLOGICALSD05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE
D05B ANTIPSORIATICS FOR SYSTEMIC USE
Last updated: 2024-12-27
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail: whocc@fhi.no
Copyright/Disclaimer
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail: whocc@fhi.no
Copyright/Disclaimer
D05 ANTIPSORIATICS